Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopy

Developing rational targeted cancer drugs requires the implementation of pharmacodynamic (PD), preferably non-invasive, biomarkers to aid response assessment and patient follow-up. Magnetic resonance spectroscopy (MRS) allows the non-invasive study of tumour metabolism. We describe the MRS-detectabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Beloueche-Babari, M, Chung, Y-L, Al-Saffar, N M S, Falck-Miniotis, M, Leach, M O
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813738/
https://www.ncbi.nlm.nih.gov/pubmed/19935796
http://dx.doi.org/10.1038/sj.bjc.6605457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813738/
https://www.ncbi.nlm.nih.gov/pubmed/19935796
http://dx.doi.org/10.1038/sj.bjc.6605457

Ejemplares similares